Clinical Pathways Search Results

This pathway provides guidance for identifying neonates symptomatic at or near the time of birth from Hypoxic-Ischemic Encephalopathy (HIE) who may be eligible whole body cooling.

The penicillin drug allergy pathway is meant to guide providers in assessing whether patients with a reported or labeled penicillin drug allergy should avoid penicillin, remove the allergy label, or refer to an allergist for skin testing or oral drug challenge.

Pre-op and post-op care for patients with Jeunes Syndrome/Chest Wall Hypoplasia treated at CHOP for insertion of a Vertical Expandable Prosthetic Titanium Rib (VEPTR)

This pathway guides the care of children who present with onset of flaccid weakness in one or more extremities +/- bulbar/cranial nerve findings without other clear cause. 

The PICU central diabetes insipidus pathway provides guidance for the care of patients with known or suspected central diabetes insipidus requiring ICU care.

The unprovoked seizure clinical pathway outlines the steps to standardize the ED clinical assessment, evaluation and recommend Neurology follow-up for healthy children presenting with new onset unprovoked seizure(s).

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

The developmental delay/intellectual disability clinical pathway guide the evaluation of children with suspected developmental delay or intellectual disability in primary care setting. 

This pathway is intended for use in the inpatient pulmonary service and the PICU to guide care for patients with common neurodegenerative conditions affecting respiratory status.

This pathway guides the diagnosis of Somatic Symptom and Related Disorders (SSRD) where the history/physical of a patient’s chief complaint does not align with known organic medical causes.